The potential role of differentially expressed tRNA-derived fragments in high glucose-induced podocytes

References

• American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl. 1):1–11. doi:10.2337/dc21-S011.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation Atlas 10th Edition; 2021 [cited 2022 Aug 1]. Available from: https://diabetesatlas.org/atlas/tenth-edition/
   Google Scholar
• Mohandes S, Doke T, Hu H, et al. Molecular pathways that drive diabetic kidney disease. J Clin Invest. 2023;133(4):e165654. doi:10.1172/JCI165654.
   PubMed Web of Science ®Google Scholar
• Dalla Vestra M, Masiero A, Roiter AM, et al. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes. 2003;52(4):1031–1035. doi:10.2337/diabetes.52.4.1031.
   PubMed Web of Science ®Google Scholar
• Watts AJB, Keller KH, Lerner G, et al. Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology. J Am Soc Nephrol. 2022;33(1):238–252. doi:10.1681/ASN.2021060794.
   PubMed Web of Science ®Google Scholar
• Ozawa S, Matsubayashi M, Nanaura H, et al. Proteolytic cleavage of podocin by matriptase exacerbates podocyte injury. J Biol Chem. 2020;295(47):16002–16012. doi:10.1074/jbc.RA120.013721.
   PubMed Web of Science ®Google Scholar
• Kakimoto T, Okada K, Hirohashi Y, et al. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic torii rats treated with losartan. J Endocrinol. 2014;222(1):43–51. doi:10.1530/JOE-14-0164.
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang X, Shi J, et al. Origins and evolving functionalities of tRNA-derived small RNAs. Trends Biochem Sci. 2021;46(10):790–804. doi:10.1016/j.tibs.2021.05.001.
   PubMed Web of Science ®Google Scholar
• Weng Q, Wang Y, Xie Y, et al. Extracellular vesicles-associated tRNA-derived fragments (tRFs): biogenesis, biological functions, and their role as potential biomarkers in human diseases. J Mol Med. 2022;100(5):679–695. doi:10.1007/s00109-022-02189-0.
   PubMed Web of Science ®Google Scholar
• Thompson DM, Lu C, Green PJ, et al. tRNA cleavage is a conserved response to oxidative stress in eukaryotes. RNA. 2008;14(10):2095–2103. doi:10.1261/rna.1232808.
   PubMed Web of Science ®Google Scholar
• Gebetsberger J, Wyss L, Mleczko AM, et al. A tRNA-derived fragment competes with mRNA for ribosome binding and regulates translation during stress. RNA Biol. 2017;14(10):1364–1373. doi:10.1080/15476286.2016.1257470.
   PubMed Web of Science ®Google Scholar
• Honda S, Loher P, Shigematsu M, et al. Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers. Proc Natl Acad Sci U S A. 2015;112(29):E3816–E3825. doi:10.1073/pnas.1510077112.
   PubMed Web of Science ®Google Scholar
• Maute RL, Schneider C, Sumazin P, et al. tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma. Proc Natl Acad Sci U S A. 2013;110(4):1404–1409. doi:10.1073/pnas.1206761110.
   PubMed Web of Science ®Google Scholar
• Guzzi N, Bellodi C. Novel insights into the emerging roles of tRNA-derived fragments in mammalian development. RNA Biol. 2020;17(8):1214–1222. doi:10.1080/15476286.2020.1732694.
   PubMed Web of Science ®Google Scholar
• Fu M, Gu J, Wang M, et al. Emerging roles of tRNA-derived fragments in cancer. Mol Cancer. 2023;22(1):30. doi:10.1186/s12943-023-01739-5.
   PubMed Web of Science ®Google Scholar
• Li D, Zhang H, Wu X, et al. Role of tRNA derived fragments in renal ischemia–reperfusion injury. Ren Fail. 2022;44(1):815–825. doi:10.1080/0886022X.2022.2072336.
   PubMed Web of Science ®Google Scholar
• Pan Q, Han T, Li G. Novel insights into the roles of tRNA-derived small RNAs. RNA Biol. 2021;18(12):2157–2167. doi:10.1080/15476286.2021.1922009.
   PubMed Web of Science ®Google Scholar
• Shi H, Yu M, Wu Y, et al. tRNA-derived fragments (tRFs) contribute to podocyte differentiation. Biochem Biophys Res Commun. 2020;521(1):1–8. doi:10.1016/j.bbrc.2019.09.009.
   PubMed Web of Science ®Google Scholar
• Li S, Liu Y, He X, et al. tRNA-derived fragments in podocytes with adriamycin-induced injury reveal the potential mechanism of idiopathic nephrotic syndrome. Biomed Res Int. 2020;2020:7826763. doi:10.1155/2020/7826763.
   PubMed Web of Science ®Google Scholar
• Ji J, Rong J, Zheng H, et al. Expression profiles of tRNA‑derived fragments in high glucose‑treated tubular epithelial cells. Exp Ther Med. 2022;25(1):26. doi:10.3892/etm.2022.11725.
   PubMed Web of Science ®Google Scholar
• Shirato I, Hosser H, Kimura K, et al. The development of focal segmental glomerulosclerosis in Masugi nephritis is based on progressive podocyte damage. Virchows Arch. 1996;429(4–5):255–273. doi:10.1007/BF00198342.
   PubMed Web of Science ®Google Scholar
• Mishima E, Inoue C, Saigusa D, et al. Conformational change in transfer RNA is an early indicator of acute cellular damage. J Am Soc Nephrol. 2014;25(10):2316–2326. doi:10.1681/ASN.2013091001.
   PubMed Web of Science ®Google Scholar
• Jia Y, Tan W, Zhou Y. Transfer RNA-derived small RNAs: potential applications as novel biomarkers for disease diagnosis and prognosis. Ann Transl Med. 2020;8(17):1092–1092. doi:10.21037/atm-20-2797.
   PubMed Web of Science ®Google Scholar
• Kumar P, Anaya J, Mudunuri SB, et al. Meta-analysis of tRNA derived RNA fragments reveals that they are evolutionarily conserved and associate with AGO proteins to recognize specific RNA targets. BMC Biol. 2014;12(1):78. doi:10.1186/s12915-014-0078-0.
   PubMedGoogle Scholar
• Han L, Lai H, Yang Y, et al. A 5′-tRNA halve, tiRNA-Gly promotes cell proliferation and migration via binding to RBM17 and inducing alternative splicing in papillary thyroid cancer. J Exp Clin Cancer Res. 2021;40(1):222. doi:10.1186/s13046-021-02024-3.
   PubMed Web of Science ®Google Scholar
• Green D, Singh A, Tippett VL, et al. YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD522. J Bone Oncol. 2023;39:100474. doi:10.1016/j.jbo.2023.100474.
   PubMed Web of Science ®Google Scholar
• Gebetsberger J, Zywicki M, Künzi A, et al. tRNA-derived fragments target the ribosome and function as regulatory non-coding RNA in Haloferax volcanii. Archaea. 2012;2012:260909–260911. doi:10.1155/2012/260909.
   PubMed Web of Science ®Google Scholar
• Magee R, Rigoutsos I. On the expanding roles of tRNA fragments in modulating cell behavior. Nucleic Acids Res. 2020;48(17):9433–9448. doi:10.1093/nar/gkaa657.
   PubMed Web of Science ®Google Scholar
• Ivanov P, Emara MM, Villen J, et al. Angiogenin-induced tRNA fragments inhibit translation initiation. Mol Cell. 2011;43(4):613–623. doi:10.1016/j.molcel.2011.06.022.
   PubMed Web of Science ®Google Scholar
• Boskovic A, Bing XY, Kaymak E, et al. Control of noncoding RNA production and histone levels by a 5′ tRNA fragment. Genes Dev. 2020;34(1–2):118–131. doi:10.1101/gad.332783.119.
   PubMed Web of Science ®Google Scholar
• Canaud G, Bienaimé F, Viau A, et al. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat Med. 2013;19(10):1288–1296. doi:10.1038/nm.3313.
   PubMed Web of Science ®Google Scholar
• Das F, Ghosh-Choudhury N, Lee DY, et al. Akt2 causes TGFβ-induced deptor downregulation facilitating mTOR to drive podocyte hypertrophy and matrix protein expression. PLOS One. 2018;13(11):e0207285. doi:10.1371/journal.pone.0207285.
   PubMed Web of Science ®Google Scholar
• Fei B, Zhou H, He Z, et al. KCNQ1OT1 inhibition alleviates high glucose-induced podocyte injury by adsorbing miR-23b-3p and regulating Sema3A. Clin Exp Nephrol. 2022;26(5):385–397. doi:10.1007/s10157-021-02173-x.
   PubMed Web of Science ®Google Scholar
• Doi K, Noiri E, Nangaku M, et al. Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit. Nephrol Dial Transplant. 2014;29(1):73–80. doi:10.1093/ndt/gft414.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Qian L, Yang R, et al. LncRNA TCF7 contributes to high glucose-induced damage in human podocytes by up-regulating SEMA3A via sponging miR-16-5p. J Diabetes Investig. 2023;14(2):193–204. doi:10.1111/jdi.13904.
   PubMed Web of Science ®Google Scholar
• Salicioni AM, Gaultier A, Brownlee C, et al. Low density lipoprotein receptor-related protein-1 promotes beta1 integrin maturation and transport to the cell surface. J Biol Chem. 2004;279(11):10005–10012. doi:10.1074/jbc.M306625200.
   PubMed Web of Science ®Google Scholar
• Kamranvar SA, Rani B, Johansson S. Cell cycle regulation by integrin-mediated adhesion. Cells. 2022;11(16):2521. doi:10.3390/cells11162521.
   PubMed Web of Science ®Google Scholar
• Chen CA, Chang JM, Chang EE, et al. TGF-β1 modulates podocyte migration by regulating the expression of integrin-β1 and -β3 through different signaling pathways. Biomed Pharmacother. 2018;105:974–980. doi:10.1016/j.biopha.2018.06.054.
   PubMed Web of Science ®Google Scholar
• Schunk SJ, Floege J, Fliser D, et al. WNT-β-catenin signalling – a versatile player in kidney injury and repair. Nat Rev Nephrol. 2021;17(3):172–184. doi:10.1038/s41581-020-00343-w.
   PubMed Web of Science ®Google Scholar
• Bose M, Almas S, Prabhakar S. Wnt signaling and ­podocyte dysfunction in diabetic nephropathy. J Investig Med. 2017;65(8):1093–1101. doi:10.1136/jim-2017-000456.
   PubMed Web of Science ®Google Scholar
• Mansfeld J, Ulbrich-Hofmann R. Modulation of phospholipase D activity in vitro. Biochim Biophys Acta. 2009;1791(9):913–926. doi:10.1016/j.bbalip.2009.03.003.
   PubMed Web of Science ®Google Scholar
• Bernfeld E, Menon D, Vaghela V, et al. Phospholipase D-dependent mTOR complex 1 (mTORC1) activation by glutamine. J Biol Chem. 2018;293(42):16390–16401. doi:10.1074/jbc.RA118.004972.
   PubMed Web of Science ®Google Scholar
• Huynh C, Ryu J, Lee J, et al. Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases. Nat Rev Nephrol. 2023;19(2):102–122. doi:10.1038/s41581-022-00648-y.
   PubMed Web of Science ®Google Scholar
• Reddy GR, Pushpanathan MJ, Ransom RF, et al. Identification of the glomerular podocyte as a target for growth hormone action. Endocrinology. 2007;148(5):2045–2055. doi:10.1210/en.2006-1285.
   PubMed Web of Science ®Google Scholar
• Mukhi D, Kolligundla LP, Maruvada S, et al. Growth hormone induces transforming growth factor-β1 in podocytes: implications in podocytopathy and proteinuria. Biochim Biophys Acta Mol Cell Res. 2023;1870(2):119391. doi:10.1016/j.bbamcr.2022.119391.
   PubMed Web of Science ®Google Scholar